John Keller - Shionogi Executive Officer
| SGIOY Stock | USD 6.93 0.07 1.02% |
Executive
John Keller is Executive Officer of Shionogi Co Ltd since 2016.
| Age | 58 |
| Tenure | 8 years |
| Phone | 81 6 6202 2161 |
| Web | https://www.shionogi.com |
Shionogi Management Efficiency
The company has return on total asset (ROA) of 0.1067 % which means that it generated a profit of $0.1067 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2014 %, meaning that it generated $0.2014 on every $100 dollars invested by stockholders. Shionogi's management efficiency ratios could be used to measure how well Shionogi manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jiny MBA | Bausch Health Companies | 47 | |
| MBA MPA | Evotec SE ADR | 56 | |
| Bart Dunn | Collegium Pharmaceutical | N/A | |
| Marc Beaudoin | Sunshine Biopharma | 57 | |
| Cees Heiman | Bausch Health Companies | N/A | |
| Robert MD | Dynavax Technologies | 70 | |
| Yoshihiro Nakagawa | Takeda Pharmaceutical Co | 64 | |
| Donald Pearl | Bausch Health Companies | N/A | |
| Malek Chamoun | Sunshine Biopharma | 39 | |
| Aurelie Dalbiez | Evotec SE ADR | 47 | |
| Kathleen Fitzpatrick | Bausch Health Companies | N/A | |
| Mary Fritz | Prestige Brand Holdings | N/A | |
| Josh Coyle | Bausch Health Companies | N/A | |
| Donn Casale | Dynavax Technologies | N/A | |
| Gabriele Hansen | Evotec SE ADR | N/A | |
| Todd MBA | Supernus Pharmaceuticals | N/A | |
| Seana Carson | Bausch Health Companies | 51 | |
| Christopher OReilly | Takeda Pharmaceutical Co | N/A | |
| RN Esq | Supernus Pharmaceuticals | 69 | |
| Arthur Shannon | Bausch Health Companies | N/A | |
| Jeff Coon | Dynavax Technologies | 61 | |
Management Performance
Shionogi Leadership Team
Elected by the shareholders, the Shionogi's board of directors comprises two types of representatives: Shionogi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shionogi. The board's role is to monitor Shionogi's management team and ensure that shareholders' interests are well served. Shionogi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shionogi's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kohji Hanasaki, Sr Division | ||
| Isao Teshirogi, CEO and President and Representative Director | ||
| Kazuhiro Hatanaka, Executive Officer | ||
| Ryuichi Kiyama, Executive Officer | ||
| Yoshihiro Furuya, VP Office | ||
| Takeshi Shiota, Executive Officer | ||
| John Keller, Executive Officer | ||
| Akira Kato, General Manager of Bus. Devel. Department | ||
| Susumu Mitsumori, VP Department | ||
| Yoshimasa Kyokawa, VP Office |
Shionogi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shionogi a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.44 % | |||
| Operating Margin | 0.43 % | |||
| Current Valuation | 11.39 B | |||
| Shares Outstanding | 1.19 B | |||
| Shares Owned By Institutions | 0.13 % | |||
| Price To Earning | 15.59 X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 0.04 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Shionogi Pink Sheet Analysis
When running Shionogi's price analysis, check to measure Shionogi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shionogi is operating at the current time. Most of Shionogi's value examination focuses on studying past and present price action to predict the probability of Shionogi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shionogi's price. Additionally, you may evaluate how the addition of Shionogi to your portfolios can decrease your overall portfolio volatility.